Investors Alert: Hims & Hers Class Action Lawsuit Deadlines Approaching

Hims & Hers Health Shareholder Alert

Kahn Swick & Foti, LLC, a prominent securities litigation law firm, has issued an alert to investors regarding important deadlines associated with a class action lawsuit against Hims & Hers Health, Inc. If investors have incurred losses exceeding $100,000 while purchasing Hims securities between April 29, 2025, and June 23, 2025, they need to be especially vigilant. The deadline for filing lead plaintiff applications is set for August 25, 2025.

Details of the Lawsuits

The lawsuits allege that Hims & Hers Health and certain executives failed to disclose critical information during the specified period, which violates federal securities laws. A significant turning point occurred on June 23, 2025, when Novo Nordisk terminated its partnership with Hims. The decision came after it was revealed that Hims failed to comply with regulations against mass sales of compounded drugs. This led to claims of deceptive marketing practices that jeopardized patient safety. Following this announcement, Hims' stock fell dramatically by 34.6%, reflecting a loss of nearly $22.24 per share amid robust trading activity.

It’s essential for any investor who purchased shares during the class period to consider their legal rights and potential recovery options. The first case was filed under Sookdeo v. Hims & Hers Health, Inc., followed by a related case expanding the class period.

Taking Action

If you are a shareholder impacted by these developments, action must be taken promptly to protect your interests. Kahn Swick & Foti provides a no-obligation consultation for investors wishing to understand their options. You can reach KSF managing partner Lewis Kahn toll-free at 1-877-515-1850 or via email at [email protected]. Additional information is also available by visiting their dedicated webpage highlighting the case details.

About Kahn Swick & Foti, LLC

Kahn Swick & Foti is recognized nationally as a leading firm specializing in securities litigation. With offices across key locations, including New York, California, and Louisiana, the firm has achieved a notable reputation in recovering investments lost to corporate misconduct. KSF has been ranked among the top firms based on total settlement value, reflecting its commitment to serving both institutional and retail investors. By addressing fraudulent activities and malfeasance in publicly traded companies, they strive to recover the losses investors face due to corporate improprieties.

This alert serves not only as a caution to those who have invested in Hims & Hers but also emphasizes the critical nature of investor awareness in the face of corporate transparency issues. Act now to assess your situation and ensure your rights are protected as these legal proceedings unfold.